A series of recent studies highlights widening gaps in mental health access, shifting prescription patterns and mixed outcomes across behavioral healthcare in the U.S. The findings point to growing pressures on providers, uneven availability of services and emerging questions around…
Research & Analysis
Children’s Hospital of Philadelphia increased average monthly naloxone, known as Narcan, co-prescribing for patients receiving outpatient opioid prescriptions from 3% to 84.1% through an enterprisewide quality improvement initiative, according to a study published June 16 in The Journal of Pediatrics. The…
A majority of adults age 50 and older have never heard of the 988 Suicide & Crisis Lifeline, despite the nationwide service receiving more than 26 million calls, texts and chats since its launch four years ago, according to a…
Vizient projects behavioral health outpatient volumes to grow 22% over the next decade, more than seven times the 3% increase predicted by population trends alone, according to the company’s 2026 Impact of Change forecast. Vizient’s forecast models 10-year demand projections…
Extreme opioid tolerance among illicit fentanyl users may be a major reason methadone induction has become more difficult in the fentanyl era, according to a study published June 9 in the Drug and Alcohol Dependence. Researchers from University of California…
Advertisement
Pediatric cannabis exposures jumped more than 6,000% among U.S. children younger than 6 between 2009 and 2024, according to a study published June 26 in the Journal of Addiction Medicine. Researchers from the Medical College of Wisconsin in Milwaukee and…
Emergency department visits for suspected suicide attempts declined overall from Jan. 1, 2021 to Dec. 31, but adolescents continued to have the highest visit proportions and adults age 26 and older saw increases, according to a CDC study published June…
Rural communities had about one-fourth the psychologist workforce rate of urban areas, making psychologists the most underrepresented healthcare profession examined in a new study published June 9 in Annals of Internal Medicine. Researchers from University of Kentucky in Lexington and…
GLP-1 receptor agonist use was associated with a 75% reduction in the odds of any substance use disorder among adults with Type 2 diabetes or obesity compared with non-user participants, according to a study published in Frontiers on March 9. …
The U.S. overdose death rate fell 24.4% from 2023 to 2024, marking the first decline across all four previously defined waves of the overdose crisis, including the fentanyl- and stimulant-driven “fourth wave,” according to a study published June 2 in…